Appendix B: Panel Roster and Financial Disclosures

Hepatitis C Virus

Member Institution Financial Disclosure
Company Relationship
Meena Bansal Icahn School of Medicine at Mount Sinai None N/A
Arthur Kim Harvard Medical School Kintor Pharmaceuticals Data Monitoring Committee
Nina Kim University of Washington School of Medicine and School of Public Health Gilead FOCUS grant Research Support (paid to institution)
Susanna Naggie Duke University School of Medicine Vir Biotechnology Equity Interest
Vir Biotechnology

Bio Marin

Theratechnologies
Scientific Advisor Board
AbbVie

Gilead Sciences
Research Support (paid to institution)
FHI360

PRA/BMS
Adjudication Committee
Mark Sulkowski Johns Hopkins University School of Medicine Arbutus

Assembly Bio

Atea

Antios Therapeutics

AbbVie

Gilead Sciences

Virion

 
Scientific Advisory Board
AbbVie

Assembly Bio

Gilead Sciences

Janssen

Contrafect

EigerBio
Research Support (paid to institution)
Merceditas Villanueva Yale University School of Medicine None N/A
David Wyles* Denver Health Medical Center and University of Colorado Denver School of Medicine Gilead Sciences Research Support (paid to institution)
* Section Group Lead
Note: Members are required to update disclosures annually and to notify guideline staff of any relevant changes in status during the interim.

 

Download Guidelines